CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-16 | Gagnon Robert E. Chief Financial Officer | Sale | −16,627 | $1.03 | $17K | 591,253 |
| 2022-05-14 | Paterson Dan President and COO | Grant or award | +15,000 | 492,933 | ||
| 2022-05-14 | Stuglik Brian M Chief Executive Officer | Grant or award | +50,000 | 1,177,607 | ||
| 2022-05-14 | Gagnon Robert E. Chief Financial Officer | Grant or award | +50,000 | 607,880 | ||
| 2022-05-12 | ROBERTSON MICHELLE Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-05-12 | Kauffman Michael Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-05-12 | JOHNSON JOHN Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-05-12 | Rowinsky Eric K Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-05-12 | Solomon Lesley Kim Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-05-12 | Bunn Paul A. Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-05-02 | Stuglik Brian M Chief Executive Officer | Sale | −5,857 | $1.41 | $8K | 1,127,607 |
| 2022-03-21 | Paterson Dan President and COO | Sale | −2,818 | $1.27 | $4K | 477,933 |
| 2022-03-21 | Stuglik Brian M Chief Executive Officer | Sale | −3,507 | $1.27 | $4K | 1,133,464 |
| 2022-03-21 | Gagnon Robert E. Chief Financial Officer | Sale | −1,409 | $1.27 | $2K | 557,880 |
| 2022-01-31 | Stuglik Brian M Chief Executive Officer | Sale | −5,695 | $1.48 | $8K | 1,136,971 |
| 2022-01-03 | Stuglik Brian M Chief Executive Officer | Sale | −26,033 | $2.05 | $53K | 1,142,666 |
| 2022-01-03 | Gagnon Robert E. Chief Financial Officer | Sale | −19,612 | $2.05 | $40K | 559,289 |
| 2022-01-03 | Paterson Dan President and COO | Sale | −23,534 | $2.05 | $48K | 480,751 |
| 2021-12-20 | Stuglik Brian M Chief Executive Officer | Sale | −13,682 | $2.27 | $31K | 1,168,699 |
| 2021-12-20 | Paterson Dan President and COO | Sale | −10,994 | $2.27 | $25K | 504,285 |
Page 15 of 17 · 326 trades